| Date Filed | Type | Description |
| 12/12/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/07/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/07/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 11/09/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 08/08/2017 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 07/26/2017 |
8-K
| Quarterly results |
| 07/18/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,250 shares
@ $6.5, valued at
$8.1k
Exercised 2,663 options to buy
@ $0 |
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,175 shares
@ $6.75, valued at
$7.9k
|
|
| 06/20/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,300 shares
@ $6.95, valued at
$9k
Exercised 2,664 options to buy
@ $0 |
|
| 06/02/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 3,380 shares
@ $7.38, valued at
$24.9k
Exercised 7,473 options to buy
@ $0 |
|
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2017 |
8-K
| Form 8-K - Current report |
| 05/25/2017 |
8-K
| Form 8-K - Current report |
| 05/18/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,275 shares
@ $6.15, valued at
$7.8k
Exercised 2,663 options to buy
@ $0 |
|
| 05/10/2017 |
10-Q
| Quarterly Report for the period ended March 31, 2017 |
| 05/10/2017 |
8-K
| Form 8-K - Current report |
| 05/02/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,100 shares
@ $6.15, valued at
$6.8k
|
|
| 05/02/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 04/27/2017 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/17/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,320 shares
@ $6.48, valued at
$8.6k
Exercised 2,664 options to buy
@ $0 |
|
| 04/05/2017 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements |
| 04/05/2017 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 04/04/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 03/15/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 03/13/2017 |
3/A
| SBI Incubation Co., Ltd. (10% Owner) has filed a Form 3/A on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2017 |
3
| SBI Incubation Co., Ltd. (10% Owner) has filed a Form 3 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
| 03/02/2017 |
4
| DANSE EDWARD H (Chief Business Officer) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 1,250 shares
@ $7.72, valued at
$9.7k
|
|
| 03/02/2017 |
4
| GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD|
Txns:
| Sold 3,550 shares
@ $7.7, valued at
$27.3k
Exercised 7,473 options to buy
@ $0 |
|
| 02/23/2017 |
8-K
| Form 8-K - Current report |
| 02/21/2017 |
4
| SCHEIBLER LUKAS (EVP of Research & Development) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD |
|